Global Retirement Partners, LLC Arcus Biosciences, Inc. Transaction History

Global Retirement Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$19.7 - $35.71 $197 - $357	-10 Reduced 43.48%	13 $0
Q3 2022 Nov 03, 2022	SELL	$23.23 - $30.07 $69 - $90	-3 Reduced 11.54%	23 $1,000
Q2 2022 Jul 15, 2022	SELL	$17.23 - $37.73 $396 - $867	-23 Reduced 46.94%	26 $1,000
Q1 2022 Jul 14, 2022	BUY	$28.92 - $41.83 $1,417 - $2,049	49 New	49 $1,000

200

51.5M

236K

141K

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.02B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Global Retirement Partners, LLC with notifications on news.